Bexarotene Reduces Production of CCL22 From Tumor-Associated Macrophages in Cutaneous T-Cell Lymphoma
Kayo Tanita(Tohoku University), Setsuya Aiba(Tohoku University), Taku Fujimura(Tohoku University), Hideki Nakajima(Kōchi University), Yumi Kambayashi(Tohoku University), Azusa Miyashita(Kumamoto University), Dai Ogata(University of Miyazaki), Akimichi Morita(Mizuho (Japan)), Yota Sato(Tohoku University), Satoshi Fukushima(Niigata Cancer Center Hospital), Chunbing Lyu(Tohoku University), Motoki Nakamura(Nagoya City University)
Cited by 48
Related Papers
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
|Cancer Cell|2022|338
Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34
|British Journal of Dermatology|1992|235
Notch signaling: Its role in epidermal homeostasis and in the pathogenesis of skin diseases
|Journal of Dermatological Science|2007|163
p38 Mitogen-activated Protein Kinase and Extracellular Signal-regulated Kinases Play Distinct Roles in the Activation of Dendritic Cells by Two Representative Haptens, NiCl2 and 2,4-dinitrochlorobenzene
|Journal of Investigative Dermatology|2003|157
Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients
|Annals of Oncology|2020|140